EP Patent

EP0426029A1 — Injectable formulation for lipophilic drugs

Assigned to Abbott Laboratories · Expires 1991-05-08 · 35y expired

What this patent protects

An injectable drug composition including a therapeutically effective amount of a lipophilic drug and a bile salt.

USPTO Abstract

An injectable drug composition including a therapeutically effective amount of a lipophilic drug and a bile salt.

Drugs covered by this patent

Patent Metadata

Patent number
EP0426029A1
Jurisdiction
EP
Classification
—
Expires
1991-05-08
Drug substance claim
No
Drug product claim
No
Assignee
Abbott Laboratories
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.